The SIRT2 direct fluorescent assay kit was purchased from Cayman Chemical Company (Ann Arber, MI). All peptides were synthesized by solid phase peptide synthesis using 
Expression and purification of SIRT1, SIRT2, and SIRT3. Human SIRT1 and SIRT2 were expressed as previously described. [1] SIRT3 (101-399 aa) was expressed in BL21 cells using a pET28a-based expression vector containing an N-terminal hexahistidine (His 6 ) tag. Cells were grown in Luria-Bertani (LB) broth supplemented with Kanamycin (50 μg/mL) and Chloramphenicol (20 μg/mL) at 37 °C until OD 600 reached ~0.6. Protein overexpression was induced with 0.2 mM isopropyl 1--D-galactopyranoside (IPTG) and incubated at 16 °C for 16 h. Cells were harvested by centrifugation and lysed using EmulsiFlex-C3 High Pressure Homogenizer (AVESTIN, Inc.) in lysis buffer (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 2% glycerol). His 6 -tagged SIRT3 was purified using Ni-NTA affinity chromatography. Ni-NTA resin and the cell lysate containing SIRT3 were incubated at 4 o C for 1 h. The resin was washed with 20 mM Tris-HCl, 500 mM NaCl, 2% glycerol, and 20 mM imidazole, pH 8.0. The bound SIRT3 was eluted with 20 mM Tris-HCl, 500 mM NaCl, and 2% glycerol, 250 mM imidazole, pH 8.0. Eluted samples were analyzed by SDS-PAGE to reveal a 36 kDa band corresponding to SIRT3 with purity > 90%. Combined samples were dialyzed in buffer (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 2% glycerol) at 4 °C. Aliquots were frozen at −80 °C for further use.
Synthesis of substrate 4.
A peptide Ac-Gln(Trt)-Pro-Lys(Boc)-Lys(Myr)-OH was synthesized by solid phase peptide synthesis using a myristoyl lysine and protected amino acids on a 2-chlorotrityl resin. The protected peptide was then cleaved from the resin using a mild acidic solution (AcOH: CF 3 CH 2 OH: CH 2 Cl 2 , 1:1:8, v/v/v). [2] To a solution of Ac-Gln(Trt)-Pro-Lys(Boc)-Lys(Myr)-OH (175 mg, 0.16 mmol) and Nmethylmorpholine (NMM, 0.035 mL, 0.32 mmol) in dry CH 2 Cl 2 (2.7 mL) was added isobutylchloroformate (0.033 mL, 0.24 mmol) dropwisely at 0°C. The reaction mixture was stirred for 20 min at 0 °C. 7-Amino-4-methyl-coumarin (56 mg, 0.32 mmol) in DMF (0.3 mL) was then added at 0 °C and the reaction mixture was stirred for 16 h at room temperature, followed by evaporation and partitioning between EtOAc and water. The aqueous phase was extracted with EtOAc (3 × 15 mL). The combined organic phase was washed with brine, dried over anhydrous Na 2 SO 4 , and then evaporated to dryness. The obtained residue was deprotected with 1% triisopropylsilane in TFA (1 mL) for 1 h, and the reaction mixture was then evaporated to dryness. The resulting residue was purified using preparative HPLC. The gradient was: 100% solvent A for 10 min, 0% to 80% solvent B over 30 min, then 80% to 95% solvent B for 5 min. After lyophilization, the 
